SEEGENE (XKRX:096530) Research & Development : ₩72,659 Mil (TTM As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is SEEGENE Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. SEEGENE's Research & Development for the three months ended in Mar. 2024 was ₩19,630 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ₩72,659 Mil.

SEEGENE Research & Development Historical Data

The historical data trend for SEEGENE's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SEEGENE Research & Development Chart

SEEGENE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

9,646.96

25,947.77

75,539.40

94,738.37

72,732.87

SEEGENE Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Research & Development	Get a 7-Day Free Trial															19,703.73	17,528.18	18,106.02	17,394.94	19,629.83

SEEGENE Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩72,659 Mil.

SEEGENE (XKRX:096530) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

SEEGENE Research & Development Related Terms

Thank you for viewing the detailed overview of SEEGENE's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

SEEGENE (XKRX:096530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SEEGENE Inc (XKRX:096530) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

Taewon Building 65-5 Bangyi-Dong, Songpa-gu, Seoul, KOR, 138-050

Website

http://www.seegene.co.kr

SEEGENE Inc is engaged in the healthcare sector. The Korean firm specializes in developing upgraded technology for accurate diagnosis of various diseases. Its products include pathogen inspection solutions such as respiratory, gastrointestinal, tuberculosis and meningitis pathogens.

SEEGENE (XKRX:096530) Headlines

No Headlines